Animals have evolved defense systems for surviving in a chemically diverse environment.
INTRODUCTION
Nrf2 is a transcription factor that transactivates cytoprotective genes through a common DNA regulatory element, called the antioxidant response element or electrophile response element (18, 24) . Nrf2-target genes are multifarious and encode phase 2 detoxifying enzymes, anti-oxidant proteins, enzymes for glutathione biosynthesis, ABC transporters, scavenger receptors, transcription factors, proteases, chaperone proteins and so forth (23) . Under basal conditions, Nrf2 is rapidly degraded by proteasomes and little induction of target genes is observed. This degradation is controlled by Keap1, an Nrf2-specific adaptor protein for the Cul3 ubiquitin ligase complex (12, 20 A number of Nrf2 activators have so far been found, but interestingly no common structures were identified among them (23) . Talalay and his colleagues classified Nrf2-activating compounds into the following ten distinct classes based on their chemical structures (7) : diphenols, Michael reaction acceptors, isothiocyanates, thiocarbamates, trivalent arsenicals, 1,2-dithiole-3-thiones, hydroperoxides, vicinal dimercaptans, heavy metals and polyenes. A current pursuit is unraveling how cells detect these chemical compounds and transduce their signals into the activation of Nrf2.
Keap1 has many highly reactive cysteine residues that have the potential to sense electrophilic Nrf2 activators by forming covalent adducts with them. We and others have therefore proposed the model that Nrf2-activating compounds directly modify the sulfhydryl groups of Keap1 cysteines by oxidation, reduction or alkylation, which alters the conformation of Keap1 and ceases the ubiquitination of Nrf2 (7, 24) . In fact, mass spectrometry studies revealed that some Nrf2-activating compounds can covalently react with cysteines in mouse or human Keap1. For example, and -583 (8) , xanthohumol with Cys-151, -319 and -613 (27) , isoliquiritigenin with Cys-151 and -226 (27) and 10-shogaol with Cis-151, -257 and -368 (27) . Among these cysteine residues, Cys-151, -273 and -288 were demonstrated to be essential for regulating Nrf2 degradation in cell biological studies (21, 25, 33, 34, 43, 46) , suggesting that these, and possibly other, cysteines are sensor sites for Nrf2 activators. These findings support the model of Nrf2 activation by adduct formation between Keap1 and activating compounds, but at the same time raise several fundamental 3 KOBAYASHI ET AL. To address these questions, we systematically analyzed a variety of Nrf2 activators using zebrafish as an experimental system to compare sensor requirements under physiological conditions. We showed before that fish have a Keap1-based response system against electrophilic compounds, as in mammals (22, 38, 39) . In contrast to the mammalian system, zebrafish possess two Keap1 molecules, Keap1a and Keap1b, both of which regulate Nrf2 degradation (26) , but have different recognition specificities for Nrf2-activating compounds, as demonstrated in this paper. We now report that the Keap1-Nrf2 system comprises discrete sensor sites, including the Keap1 cysteines Cys-151 and Cys-273, for a variety of Nrf2-activating compounds.
MATERIALS AND METHODS
Fish and chemical treatments. Zebrafish embryos and larvae were obtained by natural mating.
For induction studies, fish were placed in culture dishes (embryos and larvae) or plastic chambers (adult fish) containing 100 μM diethylmaleate (DEM) (Wako), 2 μM ebselen (Ebs) (gift from K. Uchida), 40 μM 1,2-dithiole-3-thione (D3T) (gift from T. Kensler analyzed by in situ hybridization or by RT-PCR, as described previously (22, 38) . Real-time RT-PCR was performed to quantitate gstp1 expression using an ABI Prism 7700 (Applied Biosystems) and probes labeled with a reporter fluorescent dye (TaqMan probe) as described previously (26). Plasmid construction. The plasmids pCS2FLkeap1a1bC1 and pCS2FLkeap1a1bC2 were generated by inserting the cDNA encoding amino acids 2-54 or 2-148, respectively, of zebrafish Keap1a into the HindIII and PmaCI or HindIII and BglII sites, respectively, of pCS2FLkeap1b (26) .
Plasmid pCS2FLkeap1a1bC3 was generated by inserting the cDNA encoding amino acids 299-593 of zebrafish Keap1b into the BglII and XbaI sites of pCS2FLkeap1a (26) . For constructing pCS2FLmKeap1, cDNAs encoding the amino acid regions 2-7 and 8-624 were generated by annealing synthetic oligonucleotides (Hokkaido System Science) or by PCR, respectively, and inserted together into the HindIII and XbaI sites of pCS2FL (26) . Point-mutations were introduced by PCR into pCS2FLkeap1b to give plasmids pCS2FLkeap1bK124T, pCS2FLkeap1bC125S and pCS2FLkeap1bC125W. To prepare pCS2FLmKeap1C151S, pCS2FLmKeap1C273S and pCS2FLmKeap1C288S, Cys to Ser point-mutations were introduced by PCR into pCS2FLmKeap1.
All constructs were verified by DNA sequencing. Plasmids pCS2nrf2, pCS2keap1a, pCS2keap1b and pCS2Nrf2NTnGFP were described previously (22, 26) .
Injection of mRNA and morpholino oligonucleotides. Synthetic capped RNA was made with an SP6 mMESSAGE mMACHINE in vitro transcription kit (Ambion) using linearized DNA of the pCS2 derivatives described above. Nrf2-morpholino oligonucleotide (nrf2MO) was described previously (22) . mRNA or morpholino oligonucleotides were injected into yolk at the one-cell stage using an IM300 microinjector (Narishige). GFP expression was examined under the GFP filter of a 5 KOBAYASHI ET AL. α-cyano-4-hydroxycinnamic acid (2.5 mg/ml) containing 50% acetonitrile and 0.1% trifluoroacetic acid and dried on stainless steel targets at room temperature. Analyses were performed using an AXIMA-TOF2 (Shimadzu) with a nitrogen laser, as described previously (14) . All analyses took place in the positive ion mode and the instrument was calibrated immediately prior to each series of studies.
Mutant screening. Random mutations were generated by soaking male zebrafish of the AB strain in 3 mM N-ethyl-N-nitrosourea (ENU) for 1 hour between 22 and 23ºC and repeating this process 4 times at weekly intervals. Resulting males were crossed with AB females and bred to homozygosity over two generations, as previously described (3, 6) . were previously shown to be equivalent (26) . No gstp1 induction was observed for any of the compounds tested in embryos without adding exogenous Nrf2 (Fig. 2B , no injection). Supplying exogenous Nrf2 by mRNA injection induced gstp1 expression in whole embryos ( Fig. 2A and B, 7 KOBAYASHI ET AL. and gstp1 expression was analyzed. The expression of gstp1 was induced by DEM treatment in embryos overexpressing Keap1b, but not Keap1a (Fig. 2B, DEM) . Surprisingly, 15d-PGJ 2 treatment cancelled suppression by both Keap1a and Keap1b (Fig. 2B, 15d- and categorized them into three types: a Keap1b sensing-type (K1b), a Keap1a or Keap1b-sensing type (K1a/b) and a posthatch factor-sensing type (posthatch) dependent on the putative factors missing at the embryonic stages (see Fig. 2B ). SF, D3T, Ebs, tBHQ and 1,2-NQ were grouped as K1b-type, PGA 2 is K1a/b-type and CdCl 2 and AF are posthatch-type.
RESULTS

A variety of
To ascertain whether or not induction was based on cancellation of the Keap1-promoting Nrf2 degradation, we overexpressed an Nrf2 GFP-fusion protein (Nrf2NTnGFP) in zebrafish embryos and tested its stability by monitoring GFP fluorescence after DEM or 15d-PGJ 2 treatment ( Fig. 2C and D). Nrf2NTnGFP contains the Neh2 domain, a degron for Keap1-dependent degradation of Nrf2, which has been shown to be functional not only in cultured cells, but also in mouse and zebrafish (13, 26 some of the activators were specific for Keap1b gave us the unique opportunity to identify the putative sensor cysteine residues that rely on the molecular differences between Keap1a and Keap1b. We predicted that a sensor site for K1b-type compounds is present in Keap1b, but not in Keap1a. To identify these sites systematically, we constructed chimeras of Keap1a and Keap1b proteins (Fig. 3A) and compared their DEM-responding activities by examining the induction of gstp1 expression by RT-PCR, as that can provide more quantitative data than in situ hybridization.
Only embryos overexpressing C1 protein, but not C2 or C3 proteins, were responsive to DEM (Fig.   3B ). These findings indicate that the BTB domain of Keap1b is important for sensing DEM. In the BTB domain, three cysteine residues are conserved among vertebrate Keap1 (Fig. 3C) . We refer to these cysteine residues as BTB cysteines (BCs) to ease comparison among various Keap1 molecules. Though all three BCs are conserved in both Keap1a and Keap1b, the amino acid 9 KOBAYASHI ET AL. proteins. It is known that adjacent basic residues stabilize the thiolate form of the cysteine residue, thus enhancing its reactivity (2, 29) . Based on the fact that DEM could cancel the Nrf2-repression activity of Keap1b but not that of Keap1a, we predicted that BC2 is a sensor site for DEM and that the adjacent lysine residue in Keap1b and other Keap1 proteins is critical for its reactivity. In order to verify this possibility, we substituted the cysteine residue of Keap1b BC2 to serine (C125S) and its adjacent lysine to threonine (K124T) and examined the effects of these substitutions on the DEM-induced expression of gstp1 (Fig. 3D ). Both K124T and C125S substitutions reduced the response of Keap1b to DEM, implying that BC2 is indeed a sensor site for DEM. Similar results were obtained by real-time RT-PCR ( Fig. S6 in the supplemental material).
We clarified that the function of BC2 in sensing DEM is conserved among vertebrate Keap1 proteins other than zebrafish. The corresponding BC2 residue of mouse Keap1 (Cys-151) was mutated to serine and the DEM-induced expression of gstp1 was assessed (Fig. 3E) . As expected, a C151S mutation significantly reduced the activity of mouse Keap1 to respond to DEM without affecting its activity to repress Nrf2. This was also observed in the case of the DEM-induced expression of γgcsh. Other K1b-type compounds (SF, D3T, tBHQ, 1,2-NQ and Ebs) gave identical results to DEM (Figs. 3E & S7 in the supplemental material), indicating that BC2 is a sensor site for K1b-type compounds. BC2 (Cys-151) has been shown to be required for sensing tBHQ and Ebs in cultured cells (33, 46) and tBHQ in transgenic rescue mice (45) . The important point here is that BC1 and BC3 were not mutated, so we concluded that BC2 is the only in vivo sensing site for certain types of Nrf2-activating compounds.
It is natural to assume that K1b-type compounds bind directly to Keap1 BC2. Indeed, we previously demonstrated that Ebs bound to wild-type mouse Keap1, but not to Keap1C151S mutant molecules (33) . In addition, mass spectrometry studies revealed that some Nrf2-activating albeit they also bind to many other cysteine residues in Keap1. It would be debatable to state that modification of BC2 acts solely as a trigger to terminate Nrf2 degradation owing to the difficulty in isolating Keap1 proteins with modification in only BC2. We overcame this obstacle by introducing a cysteine to tryptophan mutation in Keap1b BC2 (C125W) and analyzed its effects (Fig. 3F) .
Tryptophan (MW 186) is 83 kDa larger than cysteine (MW 103), so we expected that the Cys-to-Trp substitution would mimic the binding of DEM (MW 172) or other K1b-type compounds to BC2. As a result, Keap1bC125W failed to suppress Nrf2-mediated gstp1 expression when the protein was overexpressed to a similar amount as wild-type Keap1b and Keap1a (Fig. 3G ). This was not observed in the case of the C125S mutation, in which cysteine was substituted with an amino acid of comparable size (serine, MW 87) (see Fig. 3D ). These results suggest that compounds binding to BC2 inhibit the Nrf2-repression activity of Keap1, probably due to the bulky mass on BC2 masking important regions of Keap1. For instance, the interaction between Keap1 and Cul3 would likely be perturbed, because the α-helix just after BC2 is believed to be critical for the BTB-Cul3 interaction (44) . In fact, Rachakonda et al. (31) reported recently that BC2 adduction with IAB/BIA (MW 383) disrupts the Keap1-Cul3 interaction. We hypothesize that BC2 adduction to Nrf2 activators may cease Nrf2 ubiquitination by disturbing the proper conformation of the Keap1-Cul3 complex. This hypothesis is based on the "hinge and latch" model that depicts strict regulation of Nrf2 ubiquitination (41) .
Identification of sensor cysteines for K1a/b-type Nrf2-activating compounds. We found that the BC2 mutation had no effect on sensing 15d-PGJ 2 by us and others (11, 21, 25) . To determine the sites in Keap1 modified by 15d-PGJ 2 , mouse Keap1 protein treated with or without 15d-PGJ 2 was digested with trypsin and analyzed by MALDI-TOF
MS. Peptide mass mapping by MALDI-TOF MS analysis of the trypsin fragments of native mouse
Keap1 provided identification of the peptides accounting for ~80% of the protein sequence (see Table S1 in the supplemental material). Compared with the calculated masses of the unmodified peptides, modified peptides P-1 and P-2 had an increased mass of +316 Da, corresponding to the addition of a single molecule of 15d-PGJ 2 (Fig. 4A) . The sequences and masses of the peptides were: P-1 (CHALTPR, m/z = 1113.7) and P-2 (CEILQADAR, m/z = 1334. Table S3 in the supplemental material). This observation not only indicates the specificity of the analysis, but also supports our conclusion that Cys-151 is the sensor site for K1b-type compounds.
Since MALDI-TOF MS pinpointed Cys-273 as the potential sensor site for K1a/b-type compounds, we examined the effects of Cys-to-Ser mutations at Cys-273 (C273S) and also Cys-288 (C288S) in mouse Keap1 on Nrf2-repression and the response to compounds. Mutant 12 KOBAYASHI ET AL. mKeap1C273S failed to suppress Nrf2-mediated gstp1 expression when the amount of protein overexpressed was similar to wild-type mouse Keap1 (Fig. 4C ). This result is consistent with previous reports demonstrating that a Cys-273 mutation reduces the Nrf2-repression activity of mouse Keap1 in cultured cells (25, 43, 46) and in transgenic rescued mice (45) . Basically identical effects were seen with the C273S mutation and BC2 cysteine to tryptophan mutation (see Fig. 3G ), so we hypothesized that Cys-273 adducts with K1a/b-type compounds might disrupt the normal structure of the Keap1-Cul3 complex, as in BC2 adducts with K1b-type compounds. The mouse Keap1C288S mutation did not reduce Nrf2-repression (Fig. 4C) , which was inconsistent with previous reports (25, 43, 45, 46) perhaps due to differences in experimental conditions. Since mKeap1C288S did not repress Nrf2 activity, we further analyzed its response to activators and found that the C288S mutation did not affect responses to either DEM or 15d-PGJ 2 (Fig. 4D ). This suggested that mouse Keap1 Cys-288 might not be required for Nrf2-repression or response to K1b-and K1a/b-type compounds, at least in this experimental condition. Though our present data do not exactly deny the possibility that Cys-288 is a sensor site for K1a/b-type compounds, it is plausible that Cys-273 is the major site for sensing such compounds. 
DISCUSSION
In this paper, we propose a classification system for Nrf2-activating compounds based on the combination of three mechanisms: 1) involvement of Keap1a and/or Keap1b, 2) requirement for posthatch-specific factors and 3) it275-dependency. Our systematic approach classified Nrf2-activating compounds into 6 classes ( being therapeutic to toxic. It is hard to consider that Nrf2 activation solely contributes to all of these effects. Instead, the interesting possibility exists that each compound reacts with specific target proteins unrelated to the Keap1-Nrf2 system through specific cysteine residues. Indeed, the Class 2 compound 1,2-NQ was reported to target Cys-121 in protein tyrosine phosphatase 1B (PTP1B) (14) .
Emitted as one of combustion products of fossil fuels and also formed in the atmosphere by photochemical reactions of aromatic hydrocarbons, 1,2-NQ is considered to create a variety of hazardous effects in vivo, including acute cytotoxicity, immunotoxicity and carcinogenesis.
Covalent attachment of 1,2-NQ to PTP1B reduced its activity and led to prolonged activation of epidermal growth factor receptor, followed by abnormal cell proliferation. We speculated that 1,2-NQ forms adducts to Cys-151 in Keap1, to Cys-121 in PTP1B and to specific cysteines in other proteins to instigate the cooperative induction of a variety of adverse health effects (Fig. 6B) .
Deciphering the lineup of 1,2-NQ targets to understand its toxic effects on our health should prove worthwhile. Similarly, the Class 4 compound 15d-PGJ 2 has been shown to react with some proteins (19, 42) , namely by covalent binding to specific cysteine residues identified as for example Cys-179
of IKKβ (32), Cys-38 of NFκB p65 (37), Cys-62 of NFκB p50 (1), Cys269 of cJun (30) and Cys-285 of PPARγ (36) . Protein functions are inhibited or activated by modification of these cysteines by 15d-PGJ 2 . It has been suggested that 15d-PGJ 2 , a naturally occurring derivative of prostaglandin D 2 , exerts anti-inflammatory effects in vivo (19, 42) . The carrageenan-induced pleurisy model of acute lung injury was used to demonstrate the relationship between Nrf2 activation and anti-inflammation and that accumulation of 15d-PGJ 2 mediates this relation (11) . In the same manner, inhibition or activation of other target proteins are all related to anti-inflammation.
We therefore assumed that cooperative adducts of 15d-PGJ 2 to specific cysteines in proteins including Keap1 are quite important for establishing anti-inflammatory states ( as in cancer chemoprevention (SF) (17, 28, 40) and anti-rheumatism (AF) (15, 16) . We now propose a "cysteine code" hypothesis that converts a set of cysteine modifications into specific biological effects. Breaking the cysteine code for each Nrf2-activating compound will serve to increase understanding of its therapeutic and/or toxic effects. Please note that 1,2-NQ, 15d-PGJ 2 , SF and AF were grouped into different classes in our classification. We presume that compounds in the same class share similar "cysteine codes" that lead to analogous biological effects. Electrophilic compounds that target different sets of cysteines may produce distinct biological effects.
